HOTH
Hoth Therapeutics, Inc. Common Stock
stock NASDAQ

• HOTH - Momentum callouts ("started rippin"); watch for higher-low build on 5/15-min to confirm continuation; volume expansion is the tell.

• FBIO - "Looking nice this morning"; calendar catalyst (Sept 30 FDA decision) could spark a PGEN-style pre-run; prefer pullbacks to rising VWAP.

• UTRX - RWA tokenization rails with weekly on-chain payout hashes; transparent BTC/ETH "digital safe" and lean float support steady bids; treat 0.15–0.16 zone as pivot.

• IXHL - Multiple mentions; traders eye a push >$0.70 on open; long-hold crowd cites pipeline + $20M repurchase authorization; scalpers note 10–15% ranges.

• SMX - Took a big hit, but tape "moves significantly" on light flows; thesis is simple: if volume returns, $3–5 chatter reactivates; strict risk control required.

• NASDAQ: FBIO - Date: Sept 30 FDA. Look for steady accumulation ahead of the decision.
• NASDAQ: CYCU - "135% short float" chatter; near 52-week low with insider/institution buys. Proof = reclaim + hold.
• NASDAQ: HWH - "Short squeeze" expectations; only with a high-volume base break.
• OTC: GEAT - Fundamentals: enterprise voucher workflow that books itself; hinge at 0.140.
• NASDAQ: HOTH - Momentum name - buy retests, not tops. Which spectrum slice gets your size?

Catalysts + clear triggers beat vibes. Here’s a five-pack I’m actually mapping, not manifesting.
• NASDAQ: FBIO – September 30 FDA decision is your clock. I want steady accumulation above VWAP and a late-day push through prior supply; lose the latest higher low and I stand down.
• NASDAQ: IXHL – Multiple callouts plus a $20M repurchase authorization and “over $0.70 at the open” chatter. I’ll only size on a firm 0.70–0.73 reclaim with volume; first pullback must hold from above.
• OTC: GEAT – \~$0.14 after a tight coil. Edge is back-office: meeting-window food vouchers with per-head caps and automatic ledger posting; one controlled expense replaces hundreds of reimbursements. If 0.140 accepts, trims at 0.145/0.150.
• NASDAQ: HOTH – “Started rippin” momentum. Buy retests of prior high, not tops; stop lives under the breakout bar.
• NASDAQ: CYCU – Near 52-week low with insider/institution buys and “135% short float” chatter. Proof = reclaim the 20/50-DMA and hold two sessions. Which one earns real size first?

• HOTH - “Started rippin”; see if bids stick.
• YEE - Fell to mid-$1.30s; bounce or bleed.
• UTRX - New followers post-education push; watch shelf reclaim.
• WWR - On mentions; catalyst unclear.
• SMХ - Could range; unlocks with sustained prints.

• HOTH - Started rippin; momentum crowd circling for continuation.
• UTRX - RWA/tokenization with weekly payout proofs; steady bid keeps it interesting.
• IXHL - Share repurchase auth. $20M; traders eye >$0.70; decent scalp ranges.
• FBIO - "Looking nice" pre; eyes on Sept 30 FDA decision run-up.
• SMX - Big hit, but moving on light tape; upside with real volume.

HOTH started rippin

Check HOTH

• HOTH - Momentum callouts ("started rippin"); watch for higher-low build on 5/15-min to confirm continuation; volume expansion is the tell.

• FBIO - "Looking nice this morning"; calendar catalyst (Sept 30 FDA decision) could spark a PGEN-style pre-run; prefer pullbacks to rising VWAP.

• UTRX - RWA tokenization rails with weekly on-chain payout hashes; transparent BTC/ETH "digital safe" and lean float support steady bids; treat 0.15–0.16 zone as pivot.

• IXHL - Multiple mentions; traders eye a push >$0.70 on open; long-hold crowd cites pipeline + $20M repurchase authorization; scalpers note 10–15% ranges.

• SMX - Took a big hit, but tape "moves significantly" on light flows; thesis is simple: if volume returns, $3–5 chatter reactivates; strict risk control required.

• NASDAQ: FBIO - Date: Sept 30 FDA. Look for steady accumulation ahead of the decision.
• NASDAQ: CYCU - "135% short float" chatter; near 52-week low with insider/institution buys. Proof = reclaim + hold.
• NASDAQ: HWH - "Short squeeze" expectations; only with a high-volume base break.
• OTC: GEAT - Fundamentals: enterprise voucher workflow that books itself; hinge at 0.140.
• NASDAQ: HOTH - Momentum name - buy retests, not tops. Which spectrum slice gets your size?

Catalysts + clear triggers beat vibes. Here’s a five-pack I’m actually mapping, not manifesting.
• NASDAQ: FBIO – September 30 FDA decision is your clock. I want steady accumulation above VWAP and a late-day push through prior supply; lose the latest higher low and I stand down.
• NASDAQ: IXHL – Multiple callouts plus a $20M repurchase authorization and “over $0.70 at the open” chatter. I’ll only size on a firm 0.70–0.73 reclaim with volume; first pullback must hold from above.
• OTC: GEAT – \~$0.14 after a tight coil. Edge is back-office: meeting-window food vouchers with per-head caps and automatic ledger posting; one controlled expense replaces hundreds of reimbursements. If 0.140 accepts, trims at 0.145/0.150.
• NASDAQ: HOTH – “Started rippin” momentum. Buy retests of prior high, not tops; stop lives under the breakout bar.
• NASDAQ: CYCU – Near 52-week low with insider/institution buys and “135% short float” chatter. Proof = reclaim the 20/50-DMA and hold two sessions. Which one earns real size first?

• HOTH - “Started rippin”; see if bids stick.
• YEE - Fell to mid-$1.30s; bounce or bleed.
• UTRX - New followers post-education push; watch shelf reclaim.
• WWR - On mentions; catalyst unclear.
• SMХ - Could range; unlocks with sustained prints.

• HOTH - Started rippin; momentum crowd circling for continuation.
• UTRX - RWA/tokenization with weekly payout proofs; steady bid keeps it interesting.
• IXHL - Share repurchase auth. $20M; traders eye >$0.70; decent scalp ranges.
• FBIO - "Looking nice" pre; eyes on Sept 30 FDA decision run-up.
• SMX - Big hit, but moving on light tape; upside with real volume.

HOTH started rippin

Check HOTH